Exploring High Growth Tech Stocks In February 2025
As global markets navigate a volatile start to 2025, with the Federal Reserve holding rates steady and AI competition shaking up the tech sector, investors are closely watching how these dynamics ...
Blood Plasma Derivatives Market Insights and Forecast 2025-2030 - Grifols, SK Plasma, and Fusion Health Care Lead the Competition
Rising Incidence of Hemophilia, Immunological Disorders, and the Growing Number of Surgical Procedures Worldwide is Driving Growth, at a CAGR of ~9%Dublin, Feb. 06, 2025 (GLOBE NEWSWIRE) -- The "Blood ...
The Pharma Letter2d
Grifols collaborates with start-up FcR Therapeutics
Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...
Taiwan News2d
Europe In Vitro Diagnostics (IVD) Market The Art of Aim Identifying and Targeting Your Audience through Market Segmentation
The Europe In Vitro Diagnostics (IVD) market plays a crucial role in the region’s healthcare landscape, encompassing a wide range of diagnostic tests and technologies used for disease detection, ...
Taiwan News2d
Global In Vitro Diagnostics (IVD) Market Audience Archeology Digging into the Importance of Market Segmentation
Global in vitro diagnostics (IVD) market will reach $148,393.3 million by 2031, growing by 6.3% annually over 2021-2031. The global in vitro diagnostics (IVD) market encompasses a wide range of ...
PharmaTimes3d
Grifols collaborates with startup FcR Therapeutics to develop autoimmune therapies
Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...